CC
CRL icon

Centiva Capital’s Charles River Laboratories CRL Stock Holding History

Centiva Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,867
Closed -$432K – 1626
2025
Q1 		$432K Sell
2,867
-8,644
-75% -$1.45M 0.01% 894
2024
Q4 		$2.12M Buy
11,511
+4,246
+58% +$818K 0.04% 306
2024
Q3 		$1.43M Buy
+7,265
New +$1.51M 0.03% 634
2023
Q4 		– Sell
-5,768
Closed -$1.13M – 1867
2023
Q3 		$1.13M Buy
5,768
+3,964
+220% +$814K 0.02% 575
2023
Q2 		$379K Buy
+1,804
New +$359K 0.01% 981
2022
Q3 		– Sell
-1,909
Closed -$409K – 1550
2022
Q2 		$409K Buy
+1,909
New +$466K 0.01% 1011
2021
Q4 		– Sell
-756
Closed -$312K – 1260
2021
Q3 		$312K Buy
756
+5
+0.7% +$2.08K 0.02% 771
2021
Q2 		$277K Buy
+751
New +$251K 0.01% 1077
2021
Q1 		– Sell
-968
Closed -$242K – 1187
2020
Q4 		$242K Buy
+968
New +$231K 0.01% 718
2020
Q2 		– Sell
-6,230
Closed -$786K – 689
2020
Q1 		$786K Buy
6,230
+4,748
+320% +$712K 0.04% 254
2019
Q4 		$226K Buy
+1,482
New +$205K 0.01% 638

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Centiva Capital's CRL Position: Q2 2025 in Review

Centiva Capital sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 2,867 shares — an estimated $432K sold.

Centiva Capital first reported a position in CRL in Q4 2019 and held it in 11 quarters. The position peaked at $2.12M in Q4 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Centiva Capital reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 2,867 Charles River Laboratories shares in Q2 2025, an estimated $432K.
  • Centiva Capital first reported a position in Charles River Laboratories in Q4 2019 and held it in 11 quarters.
  • Centiva Capital's Charles River Laboratories position peaked at $2.12M in Q4 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.